Literature DB >> 29637670

Monoamine Oxidase Deficiency Causes Prostate Atrophy and Reduces Prostate Progenitor Cell Activity.

Lijuan Yin1, Jingjing Li2, Chun-Peng Liao3, Boyang Jason Wu2.   

Abstract

Monoamine oxidases (MAOs) degrade a number of biogenic and dietary amines, including monoamine neurotransmitters, and play an essential role in many biological processes. Neurotransmitters and related neural events have been shown to participate in the development, differentiation, and maintenance of diverse tissues and organs by regulating the specialized cellular function and morphological structures of innervated organs such as the prostate. Here we show that mice lacking both MAO isoforms, MAOA and MAOB, exhibit smaller prostate mass and develop epithelial atrophy in the ventral and dorsolateral prostates. The cellular composition of prostate epithelium showed reduced CK5+ or p63+ basal cells, accompanied by lower Sca-1 expression in p63+ basal cells, but intact differentiated CK8+ luminal cells in MAOA/B-deficient mouse prostates. MAOA/B ablation also decreased epithelial cell proliferation without affecting cell apoptosis in mouse prostates. Using a human prostate epithelial cell line, we found that stable knockdown of MAOA and MAOB impaired the capacity of prostate stem cells to form spheres, coinciding with a reduced CD133+ /CD44+ /CD24- stem cell population and less expression of CK5 and select stem cell markers, including ALDH1A1, TROP2, and CD166. Alternative pharmacological inhibition of MAOs also repressed prostate cell stemness. In addition, we found elevated expression of MAOA and MAOB in epithelial and/or stromal components of human prostate hyperplasia samples compared with normal prostate tissues. Taken together, our findings reveal critical roles for MAOs in the regulation of prostate basal progenitor cells and prostate maintenance. Stem Cells 2018;36:1249-1258. © AlphaMed Press 2018.

Entities:  

Keywords:  Monoamine oxidases; Prostate atrophy; Prostate stem/progenitor cells

Mesh:

Substances:

Year:  2018        PMID: 29637670     DOI: 10.1002/stem.2831

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  4 in total

Review 1.  A preview of selected articles.

Authors:  Stuart P Atkinson
Journal:  Stem Cells Transl Med       Date:  2020-07       Impact factor: 6.940

2.  Epigenetic loss of heterogeneity from low to high grade localized prostate tumours.

Authors:  Sebnem Ece Eksi; Alex Chitsazan; Zeynep Sayar; George V Thomas; Andrew J Fields; Ryan P Kopp; Paul T Spellman; Andrew C Adey
Journal:  Nat Commun       Date:  2021-12-15       Impact factor: 14.919

3.  Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer.

Authors:  Wei Li; Zhe Lu; Dongqing Pan; Zejian Zhang; Hua He; Jiacheng Wu; Naixiong Peng
Journal:  J Oncol       Date:  2022-07-06       Impact factor: 4.501

4.  Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer.

Authors:  Martin Puhr; Andrea Eigentler; Florian Handle; Hubert Hackl; Christian Ploner; Isabel Heidegger; Georg Schaefer; Maximilian P Brandt; Julia Hoefer; Gabri Van der Pluijm; Helmut Klocker
Journal:  Oncogene       Date:  2021-04-01       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.